Climb Biotherapeutics, Inc. Quality Score
CLYM
Could not load quality data
This may be a temporary issue. If it persists, the ticker may not be covered yet.
SourceQuality score computed from the 10-Q filed 30 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 11 Nov 2026. How this is calculated.
Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CLYM
Held by ETFs
CLYM is in 15 US ETFs. The largest of them, with CLYM's weight in each:
iShares Russell 2000 Growth ETFIWO0.01%of the fund
State Street SPDR S&P Biotech ETFXBI0.11%of the fund
Vanguard U.S. Momentum Factor ETFVFMO0.12%of the fund
Vanguard Russell 2000 Growth ETFVTWG0.01%of the fund
iShares Micro-Cap ETFIWC0.09%of the fund
Fidelity Fundamental Small-Mid Cap ETFFFSM0.11%of the fund
Spot a number that looks wrong? Check it in CLYM's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CLYM
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.